Lipoteichoic Acid: a Specific Inhibitor of Autolysin Activity in Pneumococcus (Physiological Role of Lipoteichoic Acid/Regulation of Autolytic Enzymes)

Total Page:16

File Type:pdf, Size:1020Kb

Lipoteichoic Acid: a Specific Inhibitor of Autolysin Activity in Pneumococcus (Physiological Role of Lipoteichoic Acid/Regulation of Autolytic Enzymes) Proc. Nat. Acad. Sci. USA Vol. 72, No. 5, pp. 1690-1694, May 1975 Lipoteichoic Acid: A Specific Inhibitor of Autolysin Activity in Pneumococcus (physiological role of lipoteichoic acid/regulation of autolytic enzymes) JOACHIM-V. HOLTJE AND ALEXANDER TOMASZ The Rockefeller University, New York, N.Y. 10021 Communicated by Maclyn McCarty, February 18, 1976 ABSTRACT The choline-containing pneumococcal li- Institute, National Institutes of Health, Bethesda, Md.). poteichoic acid (Forssman antigen) is a powerful inhibitor of the homologous autolytic enzyme, an N-acetylmura- The activity of pneumococcal autolysin (N-acetylmuramyl- myl-L-alanine amidase (EC 3.5.1.28, mucopeptide amido- L-alanine amidase; EC 3.5.1.28, mucopeptide amidohydrolase) hydrolase). Low concentrations of deoxycholate can re- was determined in the following manner: 2.36 ,ug of isotope- verse the inhibition. Wall teichoic acid preparations are labeled cell walls ([methyl-3H]choline, 1.8 ,uCi/mg) and 10 ,ul inactive at several hundred-fold higher concentrations. of amidase (containing about 1.5 X 108 cell equivalent units Activation of an inactive form of autolysin by in vitro incubation with choline-containing cell walls is also in- of crude amidase extract, 15 Mug of protein per 10 Mul) were hibited by lipoteichoic acid. Addition of lipoteichoic acid mixed in a final volume of 250 Mul of 0.05 M Tris-maleate buffer to the growth medium of pneumococcal cultures causes (pH 6.7). After incubation at 370, 20 ,ul of 38% formaldehyde chain formation, resistance to stationary phase lysis, and and 20 Mul of 0.5% bovine serum albumin (BSA; Armour frac- penicillin tolerance. It is suggested that a physiological role of lipoteichoic acids may be in the in vivo control of tion IV) solution were added and the unreacted cell wall ma- autolysin activity. terial was removed by centrifugation (12,000 X g, 10 min; The participation of bacterial autolytic enzymes in a variety of TABLE 1. Inhibition of conversion of the E-form to the C-form important physiological phenomena has been postulated by amidase by lipoteichoic acid several authors. It has been suggested that replication and Choline-cell walls + E-form amidase + lipoteichoic acid enlargement of the cell walls involves the balanced action of hydrolytic and synthetic enzymes (1). Autolytic enzymes may play a role in cell division and cell separation (2-4), com- Preincubated at 00, 5 min petence for genetic transformation (5-7), and-possibly-in the infection by a pneumococcal bacteriophage (8). In addi- tion, an essential role of the autolytic system in the bacteri- Deoxycholate added cidal and bacteriolytic action of antibiotics has been demon- strated in pneumococci (9) and in Bacillus subtilis (10). Incubation at 370 Any physiological functioning of autolysins must involve careful endogenous control of their activity. In search for po- Concentration of tential cellular inhibitors of these enzymes we observed a lipoteichoic acid Amidase activity powerful inhibitory effect of the pneumococcal lipoteichoic (Jsg/ml) (% of control) acid. Various aspects of this finding are described in this com- 0.63 102 munication. 1.26 99 3.15 68 MATERIALS AND METHODS 6.30 40 The common laboratory strain of Diplococcus pneumoniae 15.75 31 R36A was used in all studies. Several of the experimental 31.50 18 procedures used have been described in previous publications. These include: the in Inactive form (E-form) of amidase was obtained from pneumo- growth of bacteria chemically defined cocci grown on ethanolamine-containing medium (14). A prepa- medium (11) with choline or ethanolamine as the amino ration of E enzyme (10 ul; containing about 1.5 X 108 of cell alcohol components; preparation and biosynthetic labeling equivalents of bacterial lysate) was mixed with choline-containing (with radioactive isotopes) of cell walls (12); preparation of cell walls (236 jug in 1 ml of 0.15 M saline containing 0.01 M lipoteichoic acid (13) and the C- and E-forms of pneumococcal potassium phosphate buffer, pH 8.0) and various amounts of autolytic enzyme (14). Formamide extraction of wall teichoic lipoteichoic acid (LTA); these components were added in rapid acid (15); the preparation of C-polysaccharide (16); periodate succession in the order indicated. "Conversion" of the E-form oxidation and nitrous acid degradation (12); and disaggrega- to the C-form amidase was allowed to proceed for 5 min at 00 tion of the lipoteichoic acid by sodium dodecyl sulfate (17) (14). Deoxycholate (25 Mul of 2% solution) was added to each reac- were all done by published procedures. The myeloma protein tion mixture (in order to annul the effect of lipoteichoic acid on (TEPC-15) was a gift of Dr. the assay of amidase activity) and the samples were incubated at M. Potter (National Cancer 370 in order to determine the activity of amidase, as described in Materials and Methods. No enzyme activity could be detected Abbreviation: LTA, lipoteichoic acid. without "conversion." 1690 Downloaded by guest on September 27, 2021 Proc. Nat. Acad.'Sci. USA 72 (1975) Lipoteichoic Acid: Inhibitor of Autolysin 1691 -j 0rz 0 h. 0 z -I J hi 0hi 0 -i hi IC o 3.5 7.0 10.5 14.0 17.5 21.0 35.0 LIPOTEICHOIC ACID (1&g/ml) FIG. 1. The inhibition of amidase action by lipoteichoic acid. Lipoteichoic acid (LTA) was added to the reaction mixtures in the amounts (dry weight) indicated on the abscissa. Enzyme was added last. Amidase assays were performed as described in Materials and Methods. Eppendorf microcentrifuge). Radioactivity in the supernatant active "C-form" enzyme by in vitro incubation with choline- solution was determined by pipetting 200 Ml portions into 5 containing cell walls (14). Table 1 shows that the pneumo- ml of "Ready-Solv" scintillator (Beckman) and counting the coccal LTA preparations can also inhibit this enzyme activa- samples in a Mark II (Nuclear Chicago) scintillation tion process. spectrometer. RESULTS Effect of Lipoteichoic Acid on Amidase Activity and on the In Vitro Activation ofAmidase. Fig. 1 illustrates the inhibitory ef- fect of lipoteichoic acid (LTA) preparations on the activity of amidase. Concentrations of LTA as low as about 1.0 sg/ml 100 o caused 50% inhibition; 2-3 pg/ml was sufficient to inhibit loo 80% of the enzyme activity. The somewhat less than com- 50 8 plete inhibition of enzyme activity (see Fig. 1) may be more 0 apparent than real, since 10-20% of the choline residues may zk - be removed from the cell walls by the choline esterase (18) that is known to be present in the crude amidase preparations. x 2. Fig. 2 shows that the addition of low concentration (0.2%) of deoxycholate can completely reverse the inhibitory effect of 0 LTA. I I Pneumococci grown on ethanolamine-containing medium F contain an abnormal form of autolytic amidase ("E-form," I.) low-molecular-weight and low-specific-activity) that can be "converted" to the high-molecular-weight and catalytically 0 100 - 02%DEOXYCHOLATE 1 5 10 15 0 FRACTION NUMBER FIG. 3. Sucrose density gradient centrifugation of a lipotei- W 50 \ 0.1% DEOXYCHOLATE choic acid preparation in the presence of absence of sodium do- co50- decyl sulfate. Lipoteichoic acid labeled with [methyl-3H]choline (0.9 mg; total radioactivity: 104 cpm) was applied to a linear 5-20% sucrose gradient containing no detergent (A) or contain- ing 0.4% sodium dodecyl sulfate (B). Centrifugation was per- cC 10_ formed in polyallomer tubes in an SW 50.1 rotor of a Spinco model L3-50 ultracentrifuge at 35,000 rpm at 140 for 18 hr. 085 1.75 425 8.50 Fractions (250 ,d) were collected through a pinhole pierced LPOTECHOIC ACMD (mg /l) through the bottom of the tubes. Fraction 1 represents the bottom FIG. 2. Deoxycholate reverses the inhibition of amidase reac- of the gradient. Detergent was removed by precipitation at 0° tion by lipoteichoic acid. Enzyme was added to the reaction mix- (17). Solid line: lipoteichoic acid (radioactivity) in 100 Ad frac- tures last. tions. Dashed line: inhibitory effect; 10 ,A fractions were tested. Downloaded by guest on September 27, 2021 1692 Biochemistry: Holtje and Tomasz Proc. Nat. Acad. Sci. USA 72 (1975) -i z 0 I. 0 8It U)f oor x 4c UA. i 0 a. C.) I>- I- C7, U Ii %'.. 7 8 9 10 11 12 13 14 6 7 8 9 10 11 12 13 14 FRACTION NUMBER FIG. 4. Fragmentation of lipoteichoic acid by nitrous acid and periodate treatments. Lipoteichoie acid (LTA) labeled with [methyl-3H1- choline was used in both experiments. Nitrous acid treatment: 80 ,g (3 X 104 cpm) of LTA in 1 ml 0.4 M sodium acetate buffer (pH 3.5) was mixed with 1 ml of 2% (w/v) NaNO2 solution and was allowed to react at room temperature for 12 hr. The reaction mixture was passed through a Sephadex G-10 column (0.9 X 28.5 cm) in 0.15 M saline (frame a in figure). Frame A shows an untreated LTA preparation. Periodate treatment: 200 ,ug (7.5 X 104 cpm) of LTA in 50 ,l of water was mixed with 1 ml of paraperiodic acid (0.025 M) in 0.5 M sodium acetate buffer, pH 4.5, at 40 and incubated in the dark for 60 hr. Excess periodate was consumed by the addition of 0.2 ml of 10% glycerol and 1.5 hr continued incubation. The reaction mixture was passed through a Sephadex G-10 column to reisolate the de- graded LTA (frame b of figure). Frame B shows control LTA after reisolation from a Sephadex G-50 column. Fractions of 25 drops were collected in each case.
Recommended publications
  • The Ligand-Specific Co-Receptor Function of CD44 for Receptor
    The ligand-specific co-receptor function of CD44 for receptor tyrosine kinases Zur Erlangung des akademischen Grades eines DOKTORS DER NATURWISSENSCHAFTEN (Dr. rer. nat.) Fakultät für Chemie und Biowissenschaften Karlsruher Institut für Technologie (KIT) - Universitätsbereich genehmigte DISSERTATION von Christian Jung aus Karlsruhe Dekan: Prof. Dr. Martin Bastmeyer Referent: PD Dr. Véronique Orian-Rousseau Korreferent: Prof. Dr. Doris Wedlich Tag der mündlichen Prüfung: 18.4.2012 I Ich versichere, dass ich meine Arbeit selbständig angefertigt und keine anderen als die angegebenen Quellen und Hilfsmittel benutzt, sowie die wörtlich oder inhaltlich übernommenen Stellen als solche kenntlich gemacht und die Satzung der Universität Karlsruhe (TH) zur Sicherung guter wissenschaftlicher Praxis in der jeweils gültigen Fassung beachtet habe. Christian Jung, März 2012 II Zusammenfassung Listeria monocytogenes, ein gram-positives Bakterium, verursacht die Krankheit Listeriose. Eine Möglichkeit, wie L.monocytogenes Wirbeltierzellen infizieren kann, ist das Binden des Bakteriums an die Rezeportyrosinkinase (RTK) Met auf der Wirtszelle durch das bakterielle Protein InlB. Dieses Binden führt zur Aktivierung von Met und schließlich zur Aufnahme in die Zelle. Der erste Teil meine Doktorarbeit zeigt, dass die Infektion von nicht-phagozytotischen Zellen mittels InlB zusätzlich vom Ko-Rezeptor CD44v6 abhängig ist. Desweiteren kann diese bakterielle Infektion mit einem CD44v6-Peptid blockiert werden. Zusätzlich zu der Ko-Rezeptorfunktion von CD44v6 für InlB und Met, die ich gezeigt habe, wurde CD44v6 bereits als Ko-Rezeptor für die Induktion von Met und VEGFR- 2 durch ihre authentischen Liganden HGF and VEGF-A identifiziert. Im zweiten und Hauptteil meiner Doktorarbeit habe ich untersucht, ob diese Ko-Rezeptorfunktion von CD44v6 spezifisch von den Liganden, den Rezeptoren oder beiden bestimmt wird.
    [Show full text]
  • Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease
    toxins Review Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease Rosalia Marcano 1, M. Ángeles Rojo 2 , Damián Cordoba-Diaz 3 and Manuel Garrosa 1,* 1 Department of Cell Biology, Histology and Pharmacology, Faculty of Medicine and INCYL, University of Valladolid, 47005 Valladolid, Spain; [email protected] 2 Area of Experimental Sciences, Miguel de Cervantes European University, 47012 Valladolid, Spain; [email protected] 3 Area of Pharmaceutics and Food Technology, Faculty of Pharmacy, and IUFI, Complutense University of Madrid, 28040 Madrid, Spain; [email protected] * Correspondence: [email protected] Abstract: It is widely recognized that periodontal disease is an inflammatory entity of infectious origin, in which the immune activation of the host leads to the destruction of the supporting tissues of the tooth. Periodontal pathogenic bacteria like Porphyromonas gingivalis, that belongs to the complex net of oral microflora, exhibits a toxicogenic potential by releasing endotoxins, which are the lipopolysaccharide component (LPS) available in the outer cell wall of Gram-negative bacteria. Endotoxins are released into the tissues causing damage after the cell is lysed. There are three well-defined regions in the LPS: one of them, the lipid A, has a lipidic nature, and the other two, the Core and the O-antigen, have a glycosidic nature, all of them with independent and synergistic functions. Lipid A is the “bioactive center” of LPS, responsible for its toxicity, and shows great variability along bacteria. In general, endotoxins have specific receptors at the cells, causing a wide immunoinflammatory response by inducing the release of pro-inflammatory cytokines and the production of matrix metalloproteinases.
    [Show full text]
  • In Vivo Dual RNA-Seq Analysis Reveals the Basis for Differential Tissue Tropism of Clinical Isolates of Streptococcus Pneumoniae
    In Vivo Dual RNA-Seq Analysis Reveals the Basis for Differential Tissue Tropism of Clinical Isolates of Streptococcus pneumoniae Vikrant Minhas,1,4 Rieza Aprianto,2,4 Lauren J. McAllister,1 Hui Wang,1 Shannon C. David,1 Kimberley T. McLean,1 Iain Comerford,3 Shaun R. McColl,3 James C. Paton,1,5,6,* Jan-Willem Veening,2,5 and Claudia Trappetti,1,5 Supplementary Information Supplementary Table 1. Pneumococcal differential gene expression in the lungs 6 h post-infection, 9-47-Ear vs 9-47M. Genes with fold change (FC) greater than 2 and p < 0.05 are shown. FC values highlighted in blue = upregulated in 9-47-Ear, while values highlighted in red = upregulated in 9- 47M. Locus tag in 9-47- Product padj FC Ear Sp947_chr_00844 Sialidase B 3.08E-10 313.9807 Sp947_chr_02077 hypothetical protein 4.46E-10 306.9412 Sp947_chr_00842 Sodium/glucose cotransporter 2.22E-09 243.4822 Sp947_chr_00841 N-acetylneuraminate lyase 4.53E-09 227.7963 scyllo-inositol 2-dehydrogenase Sp947_chr_00845 (NAD(+)) 4.36E-09 221.051 Sp947_chr_00848 hypothetical protein 1.19E-08 202.7867 V-type sodium ATPase catalytic subunit Sp947_chr_00853 A 1.29E-06 100.5411 Sp947_chr_00846 Beta-glucoside kinase 3.42E-06 98.18951 Sp947_chr_00855 V-type sodium ATPase subunit D 8.34E-06 85.94879 Sp947_chr_00851 V-type sodium ATPase subunit C 2.50E-05 72.46612 Sp947_chr_00843 hypothetical protein 2.17E-05 65.97758 Sp947_chr_00839 HTH-type transcriptional regulator RpiR 3.09E-05 61.28171 Sp947_chr_00854 V-type sodium ATPase subunit B 1.32E-06 50.86992 Sp947_chr_00120 hypothetical protein 3.00E-04
    [Show full text]
  • Investigation of Peptidyl-Prolyl Cis/Trans Isomerases in the Virulence of Staphylococcus
    Investigation of Peptidyl-prolyl cis/trans isomerases in the virulence of Staphylococcus aureus A Dissertation presented to the faculty of the College of Arts and Sciences of Ohio University In partial fulfillment of the requirements for the degree Doctor of Philosophy Rebecca A. Keogh August 2020 © 2020 Rebecca A. Keogh. All Rights Reserved. 2 This Dissertation titled Investigation of Peptidyl-prolyl cis/trans isomerases in the virulence of Staphylococcus aureus by REBECCA A. KEOGH has been approved for the Department of Biological Sciences and the College of Arts and Sciences by Ronan K. Carroll Assistant Professor of Biological Sciences Florenz Plassmann Dean, College of Arts and Sciences 3 ABSTRACT REBECCA A. KEOGH, Doctorate of Philosophy, August 2020, Biological Sciences Investigation of peptidyl-prolyl cis/trans isomerases in the virulence of Staphylococcus aureus Director of Dissertation: Ronan K. Carroll Staphylococcus aureus is a leading cause of both hospital and community- associated infections that can manifest in a wide range of diseases. These diseases range in severity from minor skin and soft tissue infections to life-threatening sepsis, endocarditis and meningitis. Of rising concern is the prevalence of antibiotic resistant S. aureus strains in the population, and the lack of new antibiotics being developed to treat them. A greater understanding of the ability of S. aureus to cause infection is crucial to better inform treatments and combat these antibiotic resistant superbugs. The ability of S. aureus to cause such diverse infections can be attributed to the arsenal of virulence factors produced by the bacterium that work to both evade the human immune system and assist in pathogenesis.
    [Show full text]
  • Novel Therapeutic Interventions Towards Improved Management of Septic Arthritis Jian Wang1* and Liucai Wang2
    Wang and Wang BMC Musculoskeletal Disorders (2021) 22:530 https://doi.org/10.1186/s12891-021-04383-6 REVIEW Open Access Novel therapeutic interventions towards improved management of septic arthritis Jian Wang1* and Liucai Wang2 Abstract Septic arthritis (SA) represents a medical emergency that needs immediate diagnosis and urgent treatment. Despite aggressive treatment and rapid diagnosis of the causative agent, the mortality and lifelong disability, associated with septic arthritis remain high as close to 11%. Moreover, with the rise in drug resistance, the rates of failure of conventional antibiotic therapy have also increased. Among the etiological agents frequently isolated from cases of septic arthritis, Staphylococcus aureus emerges as a dominating pathogen, and to worsen, the rise in methicillin- resistant S. aureus (MRSA) isolates in bone and joint infections is worrisome. MRSA associated cases of septic arthritis exhibit higher mortality, longer hospital stay, and higher treatment failure with poorer clinical outcomes as compared to cases caused by the sensitive strain i.e methicillin-sensitive S. aureus (MSSA). In addition to this, equal or even greater damage is imposed by the exacerbated immune response mounted by the patient’s body in a futile attempt to eradicate the bacteria. The antibiotic therapy may not be sufficient enough to control the progression of damage to the joint involved thus, adding to higher mortality and disability rates despite the prompt and timely start of treatment. This situation implies that efforts and focus towards studying/ understanding new strategies for improved management of sepsis arthritis is prudent and worth exploring. The review article aims to give a complete insight into the new therapeutic approaches studied by workers lately in this field.
    [Show full text]
  • 2011/109440 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date _ . 9 September 2011 (09.09.2011) 2011/109440 Al (51) International Patent Classification: [CH/CH]; Chemin Des Chevreuils 1, 1188 Gimel (CH). C12Q 1/68 (2006.01) G01N 33/53 (2006.01) HOLTERMAN, Daniel [US/US]; 14465 North 14th St., Phoenix, AZ 85022 (US). (21) International Application Number: PCT/US201 1/026750 (74) Agent: AKHAVAN, Ramin; Caris Life Sciences, Inc., 6655 N. MacArthur Blvd., Irving, TX 75039 (US). (22) International Filing Date: 1 March 201 1 (01 .03.201 1) (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, English (25) Filing Language: AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (26) Publication Language: English CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (30) Priority Data: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 61/274,124 1 March 2010 (01 .03.2010) US KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 61/357,5 17 22 June 2010 (22.06.2010) US ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, 61/364,785 15 July 2010 (15.07.2010) us NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (71) Applicant (for all designated States except US): CARIS SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, LIFE SCIENCES LUXEMBOURG HOLDINGS [LU/ TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Signal Transduction, Quorum-Sensing, and Extracellular Protease Activity in Enterococcus Faecalis Biofilm Formation
    Signal Transduction, Quorum-Sensing, and Extracellular Protease Activity in Enterococcus faecalis Biofilm Formation The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Carniol, K., and M. S. Gilmore. 2004. Signal Transduction, Quorum- Sensing, and Extracellular Protease Activity in Enterococcus Faecalis Biofilm Formation. Journal of Bacteriology 186, no. 24: 8161–8163. doi:10.1128/jb.186.24.8161-8163.2004. Published Version doi:10.1128/JB.186.24.8161-8163.2004 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:33867369 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA JOURNAL OF BACTERIOLOGY, Dec. 2004, p. 8161–8163 Vol. 186, No. 24 0021-9193/04/$08.00ϩ0 DOI: 10.1128/JB.186.24.8161–8163.2004 Copyright © 2004, American Society for Microbiology. All Rights Reserved. GUEST COMMENTARY Signal Transduction, Quorum-Sensing, and Extracellular Protease Activity in Enterococcus faecalis Biofilm Formation Karen Carniol1,2 and Michael S. Gilmore1,2* Department of Ophthalmology, Harvard Medical School,1 and The Schepens Eye Research Institute,2 Boston, Massachusetts Biofilms are surface-attached communities of bacteria, en- sponse regulator proteins (10). Only one of the mutants gen- cased in an extracellular matrix of secreted proteins, carbohy- erated, fsrA, impaired the ability of E. faecalis strain V583A to drates, and/or DNA, that assume phenotypes distinct from form biofilms in vitro.
    [Show full text]
  • Host and Bacterial Determinants of Staphylococcus Aureus Nasal Colonization in Humans
    University of Central Florida STARS Electronic Theses and Dissertations, 2004-2019 2014 Host and Bacterial Determinants of Staphylococcus aureus Nasal Colonization in Humans Gowrishankar Muthukrishnan University of Central Florida Part of the Medical Sciences Commons Find similar works at: https://stars.library.ucf.edu/etd University of Central Florida Libraries http://library.ucf.edu This Doctoral Dissertation (Open Access) is brought to you for free and open access by STARS. It has been accepted for inclusion in Electronic Theses and Dissertations, 2004-2019 by an authorized administrator of STARS. For more information, please contact [email protected]. STARS Citation Muthukrishnan, Gowrishankar, "Host and Bacterial Determinants of Staphylococcus aureus Nasal Colonization in Humans" (2014). Electronic Theses and Dissertations, 2004-2019. 1289. https://stars.library.ucf.edu/etd/1289 HOST AND BACTERIAL DETERMINANTS OF STAPHYLOCOCCUS AUREUS NASAL COLONIZATION IN HUMANS by GOWRISHANKAR MUTHUKRISHNAN M.E. Birla Institute of Technology and Science, Pilani, India, 2007 M.S. University of Central Florida, United States of America, 2010 A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Burnett School of Biomedical Sciences in the College of Medicine at the University of Central Florida Orlando, Florida Summer Term 2014 Major Professor: Alexander M. Cole © 2014 Gowrishankar Muthukrishnan ii ABSTRACT Staphylococcus aureus (SA), an opportunistic pathogen colonizing the anterior nares in approximately 30% of the human population, causes severe hospital-associated and community-acquired infections. SA nasal carriage plays a critical role in the pathogenesis of staphylococcal infections and SA eradication from the nares has proven to be effective in reducing endogenous infections.
    [Show full text]
  • Multi-Product Lactic Acid Bacteria Fermentations: a Review
    fermentation Review Multi-Product Lactic Acid Bacteria Fermentations: A Review José Aníbal Mora-Villalobos 1 ,Jéssica Montero-Zamora 1, Natalia Barboza 2,3, Carolina Rojas-Garbanzo 3, Jessie Usaga 3, Mauricio Redondo-Solano 4, Linda Schroedter 5, Agata Olszewska-Widdrat 5 and José Pablo López-Gómez 5,* 1 National Center for Biotechnological Innovations of Costa Rica (CENIBiot), National Center of High Technology (CeNAT), San Jose 1174-1200, Costa Rica; [email protected] (J.A.M.-V.); [email protected] (J.M.-Z.) 2 Food Technology Department, University of Costa Rica (UCR), San Jose 11501-2060, Costa Rica; [email protected] 3 National Center for Food Science and Technology (CITA), University of Costa Rica (UCR), San Jose 11501-2060, Costa Rica; [email protected] (C.R.-G.); [email protected] (J.U.) 4 Research Center in Tropical Diseases (CIET) and Food Microbiology Section, Microbiology Faculty, University of Costa Rica (UCR), San Jose 11501-2060, Costa Rica; [email protected] 5 Bioengineering Department, Leibniz Institute for Agricultural Engineering and Bioeconomy (ATB), 14469 Potsdam, Germany; [email protected] (L.S.); [email protected] (A.O.-W.) * Correspondence: [email protected]; Tel.: +49-(0331)-5699-857 Received: 15 December 2019; Accepted: 4 February 2020; Published: 10 February 2020 Abstract: Industrial biotechnology is a continuously expanding field focused on the application of microorganisms to produce chemicals using renewable sources as substrates. Currently, an increasing interest in new versatile processes, able to utilize a variety of substrates to obtain diverse products, can be observed.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier Et Al
    US 200601 10747A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier et al. (43) Pub. Date: May 25, 2006 (54) PROCESS FOR IMPROVED PROTEIN (60) Provisional application No. 60/591489, filed on Jul. EXPRESSION BY STRAIN ENGINEERING 26, 2004. (75) Inventors: Thomas M. Ramseier, Poway, CA Publication Classification (US); Hongfan Jin, San Diego, CA (51) Int. Cl. (US); Charles H. Squires, Poway, CA CI2O I/68 (2006.01) (US) GOIN 33/53 (2006.01) CI2N 15/74 (2006.01) Correspondence Address: (52) U.S. Cl. ................................ 435/6: 435/7.1; 435/471 KING & SPALDING LLP 118O PEACHTREE STREET (57) ABSTRACT ATLANTA, GA 30309 (US) This invention is a process for improving the production levels of recombinant proteins or peptides or improving the (73) Assignee: Dow Global Technologies Inc., Midland, level of active recombinant proteins or peptides expressed in MI (US) host cells. The invention is a process of comparing two genetic profiles of a cell that expresses a recombinant (21) Appl. No.: 11/189,375 protein and modifying the cell to change the expression of a gene product that is upregulated in response to the recom (22) Filed: Jul. 26, 2005 binant protein expression. The process can improve protein production or can improve protein quality, for example, by Related U.S. Application Data increasing solubility of a recombinant protein. Patent Application Publication May 25, 2006 Sheet 1 of 15 US 2006/0110747 A1 Figure 1 09 010909070£020\,0 10°0 Patent Application Publication May 25, 2006 Sheet 2 of 15 US 2006/0110747 A1 Figure 2 Ester sers Custer || || || || || HH-I-H 1 H4 s a cisiers TT closers | | | | | | Ya S T RXFO 1961.
    [Show full text]
  • A Bacterial Goldilocks Mechanism
    INSIGHT TWO-COMPONENT SIGNALING PATHWAYS A bacterial Goldilocks mechanism Bacillus subtilis can measure the activity of the enzymes that remodel the cell wall to ensure that the levels of activity are ‘just right’. IRENE M KIM AND HENDRIK SZURMANT detector and a transcription factor that commu- Related research article Dobihal GS, Bru- nicate with one another through the transfer of a net YR, Flores-Kim J, Rudner DZ. 2019. phosphoryl group. Homeostatic control of cell wall hydrolysis An important TCS in the soil bacterium Bacil- by the WalRK two-component signaling lus subtilis and other related bacteria is the pathway in Bacillus subtilis. eLife 8:e52088. WalRK system, which is essential for viability DOI: 10.7554/eLife.52088 (Szurmant, 2012). The system, which is com- prised of the signal-detecting protein WalK and the transcription factor WalR, gets its name from its role in maintaining the cell wall (Dubrac et al., 2007). Together these two com- hen mollusks get bigger, their shells ponents regulate the expression of several auto- grow with them to accommodate lysin genes, including those for the enzymes W the changing shape and size of the LytE and CwlO, which are required for cell elon- organism being housed. Something similar also gation (Salzberg et al., 2013). Now, in eLife, happens in bacteria. The cell wall of most bacte- David Rudner and colleagues at Harvard Medical ria consists of a single macromolecule called School – including Genevieve Dobihal and Yan- peptidoglycan that surrounds the cell and is nick Brunet as joint first authors, along with made up of modified sugars that are crosslinked Josue´ Flores-Kim – report on how the WalRK through peptide side chains.
    [Show full text]
  • The Characterization of a Putative Protease Expressed by Sneathia Amnii
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2015 The Characterization of a Putative Protease Expressed by Sneathia amnii Rana Mehr Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Medicine and Health Sciences Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/3931 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. CHARACTERIZATION OF A PUTATIVE PROTEASE EXPRESSED BY SNEATHIA AMNII A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University by RANA MEHR B.S., Virginia Commonwealth University 2011 Director: Kimberly Jefferson, Ph.D. Associate Professor, Department of Microbiology and Immunology Virginia Commonwealth University Richmond, Virginia Virginia Commonwealth University Richmond, Virginia July, 2015 Acknowledgements I would first like to express my deepest gratitude to my mentor Dr. Kimberly Jefferson. Her continuous mentorship, trust, and support in academic, scientific, and personal experiences have empowered me to successfully complete my graduate career both academically and scientifically. She has aided my development as an independent scientist which would have not been possible without guidance. I would also like to thank the members of my graduate advisory committee: Dr. Dennis Ohman and Dr. Darrell Peterson. Their advice and direction have allowed me to better understand my project and their invaluable knowledge has made me a better scientist.
    [Show full text]